MedPath

Comparison of the atrophogenic effect of hydrocortisone 1% cream and Elidel (Pimecrolimus 1% cream) assessed by Optical Coherence Tomography (OCT) and 20-MHZ ultrasound of uninvolved skin in patients with atopic dermatitis - OCT-AD-Study

Phase 1
Conditions
patients with mild to moderate atopic dermatitis not affecting the test areas
Registration Number
EUCTR2007-004279-20-DE
Lead Sponsor
Technical University Dresden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

- Age 18 -60 years
- Diagnoses of atopic dermatitis (Hanifin & Rajka Criteria)
- patients with atopic dermatitis not affecting the forehead

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- pregnancy / nursing mothers
- women in reproductive age without adequate contraception
- Severe atopic dermatitis (IGA >= 4)
- UV-Therapy in past 4 weeks
- Patients receiving any topical treatment on the face in past 6 month

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath